van Bragt JJMH, de Vries R, Sterk PJ, Maitland-van der Zee AH. Exhaled breath analysis for prediction of responders to mepolizumab in patients with severe asthma. Am J Resp Crit Care Med. 2019;199:A2673.
Anti-C5a-antilichaam vilobelimab veilig bij ernstige COVID-19
feb 2021 | Pneumonie, Virale infecties